China NT Pharma Group Co Ltd (1011) - Financial and Strategic SWOT Analysis Review

China NT Pharma Group Co Ltd (1011) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

China NT Pharma Group Co Ltd (NT Pharma) is a technology-based pharmaceutical company, which researches, develops, manufactures, and distributes branded and generic pharmaceuticals. The company also promotes and distributes drugs manufactured by third parties. It develops drugs for indications such as cancer; central nervous system disorders; orthopedics; hepatopathy and respiratory disorders. NT Pharmas branded products include Libod and Xi Di Ke for the treatment of various cancers; Miacalcic for bone pain; Shusi, an antipsychotic drug; Zhuoao, a respiratory drug, and Songzhi Wan, a traditional Chinese medicine for the treatment of Hepatitis C. The company operates three production bases for chemical drugs, traditional Chinese medicine and bio-chemical drugs through its subsidiaries, Suzhou First, Jiangsu Biopharma and Changsha Pharma. It operates a research and development facility in Beijing. NT Pharma is headquartered in Wanchai, Hong Kong.

China NT Pharma Group Co Ltd Key Recent Developments

Mar 26,2018: China NT Pharma: Annual Results Announcement For the Year Ended 31 December 2017
Aug 21,2017: China NT Pharma: Interim Results Announcement for the Six Months Ended 30 June 2017
Jul 31,2017: China NT Pharma: Appointment And Resignation Of Non-Executive Director
Mar 21,2017: China NT Pharma Group Company: Annual Results Announcement For The Year Ended 31 December 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company




Section 1 - About the Company 6
China NT Pharma Group Co Ltd - Key Facts 6
China NT Pharma Group Co Ltd - Key Employees 7
China NT Pharma Group Co Ltd - Key Employee Biographies 8
China NT Pharma Group Co Ltd - Major Products and Services 9
China NT Pharma Group Co Ltd - History 10
China NT Pharma Group Co Ltd - Company Statement 12
China NT Pharma Group Co Ltd - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 Company Analysis 14
Company Overview 14
China NT Pharma Group Co Ltd - Business Description 15
Business Segment: Miacalcic 15
Overview 15
Performance 15
Business Segment: Proprietary Products Production and Sales and Promotion 15
Overview 15
Performance 15
Geographical Segment: Hong Kong 16
Performance 16
Geographical Segment: Other Countries 16
Performance 16
Geographical Segment: PRC 16
Performance 16
R&D Overview 16
China NT Pharma Group Co Ltd - Corporate Strategy 17
China NT Pharma Group Co Ltd - SWOT Analysis 18
SWOT Analysis - Overview 18
China NT Pharma Group Co Ltd - Strengths 18
China NT Pharma Group Co Ltd - Weaknesses 19
China NT Pharma Group Co Ltd - Opportunities 20
China NT Pharma Group Co Ltd - Threats 21
China NT Pharma Group Co Ltd - Key Competitors 22
Section 3 Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios - Interim Ratios 28
Financial Ratios - Ratio Charts 29
Section 4 Companys Lifesciences Financial Deals and Alliances 30
China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
China NT Pharma Group Co Ltd, Recent Deals Summary 32
Section 5 Companys Recent Developments 33
Mar 26, 2018: China NT Pharma: Annual Results Announcement For the Year Ended 31 December 2017 33
Aug 21, 2017: China NT Pharma: Interim Results Announcement for the Six Months Ended 30 June 2017 34
Jul 31, 2017: China NT Pharma: Appointment And Resignation Of Non-Executive Director 37
Mar 21, 2017: China NT Pharma Group Company: Annual Results Announcement For The Year Ended 31 December 2016 38
Section 6 Appendix 39
Methodology 39
Ratio Definitions 39
About GlobalData 43
Contact Us 43
Disclaimer 43

List Of Tables

List of Tables
China NT Pharma Group Co Ltd, Key Facts 6
China NT Pharma Group Co Ltd, Key Employees 7
China NT Pharma Group Co Ltd, Key Employee Biographies 8
China NT Pharma Group Co Ltd, Major Products and Services 9
China NT Pharma Group Co Ltd, History 10
China NT Pharma Group Co Ltd, Subsidiaries 13
China NT Pharma Group Co Ltd, Key Competitors 22
China NT Pharma Group Co Ltd, Ratios based on current share price 23
China NT Pharma Group Co Ltd, Annual Ratios 24
China NT Pharma Group Co Ltd, Annual Ratios (Cont...1) 25
China NT Pharma Group Co Ltd, Annual Ratios (Cont...2) 26
China NT Pharma Group Co Ltd, Interim Ratios 28
China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
China NT Pharma Group Co Ltd, Recent Deals Summary 32
Currency Codes 39
Capital Market Ratios 39
Equity Ratios 40
Profitability Ratios 40
Cost Ratios 41
Liquidity Ratios 41
Leverage Ratios 42
Efficiency Ratios 42

List Of Figures

List of Figures
China NT Pharma Group Co Ltd, Performance Chart (2013 - 2017) 27
China NT Pharma Group Co Ltd, Ratio Charts 29
China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

China Galaxy Securities Co Ltd (6881) - Financial and Strategic SWOT Analysis Review

China Galaxy Securities Co Ltd (6881) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been

USD 125 View Report

China Petrochemical Development Corp (1314) - Financial and Strategic SWOT Analysis Review

China Petrochemical Development Corp (1314) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

Asia Pacific Out-patient Pharmacy Automation Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Out-patient Pharmacy Automation market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD

USD 3000 View Report

North America Out-patient Pharmacy Automation Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The North America Out-patient Pharmacy Automation market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available